STAT News

STAT+: ARPA-H to invest $62 million to develop FDA-authorized AI to help treat heart failure

ARPA-H, the government agency that funds cutting edge health research, plans to commit $62.7 million to develop artificial intelligence bots that direct treatment of heart failure.

بقلم STAT News

9 September 20261 دقيقة قراءة

Health Tech

STAT+: ARPA-H to invest $62 million to develop FDA-authorized AI to help treat heart failure

← العودة إلى أخبار IE

هل لديك أخبار لمشاركتها مع صناعة الفعاليات؟

أرسل بياناً صحفياً أو تلميحاً بقصة وتواصل مع آلاف المهنيين في مجال الفعاليات.

تواصل معنا→

رؤى ذات صلة

Change management and organizational transformation
VUCA MAX: A Strategic Framework for Analyzing Industry Futures.
How executives and professionals can read the forces reshaping industries, distinguish signal from noise, and make better decisions about what comes next.
10 Sept 202612 min read
Future Supply Chains, Logistics & Fleets
The Supply Chain That Thinks - How AI agents, quantum computing, cheap energy and programmable risk could reshape global logistics, 2026–2036
9 Sept 202619 min read
Synthetic biology and bioengineering
The Bio Revolution Is Here — And the World Is Already Choosing Sides
Biology is becoming the next great industrial platform — accelerated by AI, contested by China and the US, and creating tomorrow's careers.
8 Sept 202615 min read

Browse all insights →

STAT+: ARPA-H to invest $62 million to develop FDA-authorized AI to help treat heart failure

المزيد في Health Tech

STAT+: Leukemia drug data suggested a different way to treat diabetes. A new biotech will test that idea

An administrative gap delays access to new pancreatic cancer treatment

STAT+: Pharmalittle: We’re reading about another Novartis trial failure, a Novo Nordisk setback, and more

Opinion: AMA CEO: AI won’t replace doctors — it will work alongside them

Telemedicine company offers GLP-1s for addiction

STAT+: FDA warns an API supplier about residue on walls, a corroded product line, and open-toed sandals

رؤى ذات صلة

VUCA MAX: A Strategic Framework for Analyzing Industry Futures.

Future Supply Chains, Logistics & Fleets

The Bio Revolution Is Here — And the World Is Already Choosing Sides

STAT+: ARPA-H to invest $62 million to develop FDA-authorized AI to help treat heart failure

المزيد في Health Tech

STAT+: Leukemia drug data suggested a different way to treat diabetes. A new biotech will test that idea

An administrative gap delays access to new pancreatic cancer treatment

STAT+: Pharmalittle: We’re reading about another Novartis trial failure, a Novo Nordisk setback, and more

Opinion: AMA CEO: AI won’t replace doctors — it will work alongside them

Telemedicine company offers GLP-1s for addiction

STAT+: FDA warns an API supplier about residue on walls, a corroded product line, and open-toed sandals

رؤى ذات صلة

VUCA MAX: A Strategic Framework for Analyzing Industry Futures.

Future Supply Chains, Logistics & Fleets

The Bio Revolution Is Here — And the World Is Already Choosing Sides